Mosquito-borne diseases like Malaria, Dengue, and Chikungunya are common in warm areas. Though similar in symptoms, they ...

The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Vimkunya, a vaccine used to prevent disease caused by the chikungunya virus in people 12 years of age and older. The ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to ...

VIMKUNYA is a single dose, prefilled, adjuvanted VLP recombinant protein vaccine for active immunization for the prevention ...

Pune: There were concerning complications seen in children during last year's chikungunya outbreak, including one case which ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

Mosquitoes transmit dengue fever chikungunya and malaria but each disease has its own physiological consequences ...

Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...

Maharashtra reported a significant rise in Chikungunya cases, increasing from 473 in early 2024 to 658 by April 2025. While other vector-borne diseases like malaria and dengue show a downward trend, ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendat ...

French President Emmanuel Macron has promised more support to fight chikungunya on La Réunion, after a baby died from the ...